Tivic Health Systems, Inc. (NASDAQ: TIVC) Analyzed: Bearish Trend and Negative Fundamentals
Summary
As of August 17, 2023, Tivic Health Systems, Inc. has a market capitalization of $7.29 million, with its stock price showing a range from $0.035 to $2.08 on a year-to-date basis; however, the company's negative earnings and its stock trading below moving averages suggest a bearish trend, leading to a sell recommendation.
Fundamental Analysis
As of the close of trading on August 17, 2023, Tivic Health Systems, Inc. had a market capitalization of $7.29 million. On a year-to-date basis, the stock price of Tivic had established a range from as low as $0.035 to as high as $2.08. Its latest closing price was $0.0643, coming off a daily swing between $0.0598 and $0.1146.
Reviewing recent news, it appears that Tivic Health Systems has experienced a number of key developments that may have contributed to its stock performance. In particular, the commencement of a new clinical trial has given the stock a significant boost. However, the announcement of a public share offering at a low price of $0.041 per share stirred a significant downward shift in its market value.
From an earnings standpoint, the company reported a negative earnings per share (EPS) of $-0.96, which translated into a negative Price-to-Earnings (PE) ratio of -0.07. This is a red flag because it suggests that the company is not currently profitable. The announcement of Q1 2023 earnings that revealed a loss of $-0.11 EPS may have also contributed to the negative sentiment for the TIVC stock.
Technical Analysis
Tivic Health Systems' stock is currently trading below both the 50-day moving average ($0.0744) and the 200-day moving average ($0.44182). This is typically a bearish sign, indicating that the stock may be on a downward trend.
The RSI14 stands at 57, implying that TIVC is approaching overbought territory, which could suggest a potential pullback in the near term. The MACD (3-month) is at -0.006168, indicating a bearish trend, while the Average True Range (ATR) is relatively high at 21.648378115472, signaling high volatility.
TIVC has identified a support level at $0.0577 and a resistance level at $0.067. These levels can act as a pivot for future price movement. High trading volume of 552.008 million compared to the average volume of 24.202 million could imply strong investor interest, but it may also hint at potential price volatility in the short-term due to larger transaction volumes.
Short-Term Prediction
For the upcoming trading day on August 18, 2023, the combination of a highly volatile ATR, an RSI approaching overbought territory, and short-term bearish trend implied by the negative MACD may mean the stock price could see a slight pullback. It may be likely to test its support level at $0.0577.
Medium-Term Prediction
Over the following week, given the critical developments and high volatility, we can expect a high degree of price fluctuation. It may continue to trade within the recent range between the support and resistance, unless there's a significant update regarding the company's fundamentals.
Evaluation
In conclusion, based on the current technical and fundamental analysis, Tivic Health Systems, Inc. (NASDAQ: TIVC) appears to be a Sell. This determination is based on the company's negative earnings, its current stock price's position under the moving averages, and its high volatility. Additionally, the impact of the recent public share offering at a low price could continue to put pressure on the stock in the near term. However, the approved clinical trial could offer some economic prospects for the company in the long-term once tangible results begin to surface.
Sign In